Bright Minds Biosciences (DRUG) Total Non-Current Liabilities (2022 - 2024)
Bright Minds Biosciences (DRUG) posted Total Non-Current Liabilities of $82604.9 for Q3 2024, up 117.3% on a QoQ basis from -$477585.4 in Q2 2024, and up 120.1% year-over-year from $37530.8 in Q4 2023.
Bright Minds Biosciences (DRUG) Total Non-Current Liabilities (2022 - 2024) Analysis & Trends
Bright Minds Biosciences' Total Non-Current Liabilities history runs 3 years deep, the most recent figure standing at $82604.9 for Q3 2024.
- Quarterly Total Non-Current Liabilities rose 120.1% year-over-year to $82604.9 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $82604.9 (up 120.1% YoY) and the FY2024 annual result came in at $82604.9, up 120.1% from the prior year.
- Total Non-Current Liabilities was $82604.9 for Q3 2024 at Bright Minds Biosciences, up from -$477585.4 in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $292813.2 in Q2 2022 and bottomed at -$477585.4 in Q2 2024.
- A 3-year average of -$65315.1 and a median of $10354.7 in 2024 frame the typical range for Total Non-Current Liabilities.
- Peak annual rise in Total Non-Current Liabilities reached 120.1% in 2024, while the deepest fall reached 561.22% in 2024.
- Bright Minds Biosciences' Total Non-Current Liabilities stood at -$183567.2 in 2022, then jumped by 108.93% to $16399.2 in 2023, then soared by 403.71% to $82604.9 in 2024.
- Business Quant data shows DRUG's Total Non-Current Liabilities at $82604.9 in Q3 2024, -$477585.4 in Q2 2024, and $10354.7 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 4.45 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 110.28 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.98 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 949,738.67 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 5.87 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 7.32 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 40.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 746.94 Mn |
| 10 | Bright Minds Biosciences | 498.53 Mn | 498.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 82,604.86 |
| Jun 30, 2024 | -477,585.39 |
| Mar 31, 2024 | 10,354.71 |
| Dec 31, 2023 | 16,399.24 |
| Sep 30, 2023 | -410,991.28 |
| Jun 30, 2023 | -72,228.27 |
| Mar 31, 2023 | 154,364.28 |
| Dec 31, 2022 | -183,567.22 |
| Jun 30, 2022 | 292,813.19 |